Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

计划入组 461 人 · 首次发布于 2021 年 3 月 11 日

KRYSTAL- KetopRofen lYsinate Sore ThroAt Lozenges

计划入组 801 人 · 首次发布于 2009 年 6 月 30 日

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

计划入组 86 人 · 首次发布于 2020 年 4 月 1 日

CAN-10

BBI-10

Interleukin-10

Krystal Biotech, Inc.

United States

Krystal Biotech Netherlands, B.V.

Netherlands

iFreeETF US Treasury Bond 7-10 Year Hdg

United States

Personalized Approaches Advance in Locally Advanced and Metastatic Colorectal Cancer Treatment

Krystal Biotech's VYJUVEK Drives Revenue Growth; Expands Pipeline

FDA Approves Krystal Biotech's Vyjuvek, a Topical Gene Therapy for Dystrophic Epidermolysis Bullosa